These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26213157)

  • 1. Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients.
    Zhou Y; Wang X; Li H; Zhang J; Chen Z; Xie W; Zhang J; Li J; Zhou L; Huang M
    Drug Metab Pharmacokinet; 2015 Aug; 30(4):282-7. PubMed ID: 26213157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific OCT1 and ABCG2 polymorphisms are associated with Lamotrigine concentrations in Chinese patients with epilepsy.
    Shen CH; Zhang YX; Lu RY; Jin B; Wang S; Liu ZR; Tang YL; Ding MP
    Epilepsy Res; 2016 Nov; 127():186-190. PubMed ID: 27610747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Population Pharmacokinetic-Pharmacogenetic Model of Lamotrigine in Chinese Children With Epilepsy.
    Chen Y; Xu S; Wang Z; Zhao M; Wang H; Lu T; Zhao L
    Ther Drug Monit; 2018 Dec; 40(6):730-737. PubMed ID: 30169477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy.
    Shen C; Zhang B; Liu Z; Tang Y; Zhang Y; Wang S; Guo Y; Ding Y; Wang S; Ding M
    Seizure; 2017 Oct; 51():102-106. PubMed ID: 28837897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of UGT2B7, UGT1A4 and ABCG2 Polymorphisms on the Pharmacokinetics and Therapeutic Efficacy of Lamotrigine in Patients with Epilepsy.
    Yang J; Wang J; Ning L; Wu C; Liu Y; Xia J; Guan Y; Liu Q; Zheng J
    Eur J Drug Metab Pharmacokinet; 2024 Jul; 49(4):437-447. PubMed ID: 38709450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy.
    Klarica Domjanović I; Lovrić M; Trkulja V; Petelin-Gadže Ž; Ganoci L; Čajić I; Božina N
    Br J Clin Pharmacol; 2018 Sep; 84(9):2106-2119. PubMed ID: 29791014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics.
    Zhou Q; Ruan ZR; Yuan H; Xu DH; Zeng S
    Pharmazie; 2013 Feb; 68(2):129-34. PubMed ID: 23469685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: Recommendations for pregnant women with epilepsy.
    Wang ML; Tao YY; Sun XY; Guo Y; Wang ZY; Cao YF; Zhao L
    Pharmacol Res; 2021 Jul; 169():105610. PubMed ID: 33857625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Analysis of the Association Between CYP3A4/5, ABCB1 Genetic Polymorphisms and Oxcarbazepine Metabolism and Transport in Chinese Epileptic Patients with Oxcarbazepine Monotherapy and Bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YA; Zhou BT
    J Pharm Pharm Sci; 2015; 18(3):256-65. PubMed ID: 26517132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy.
    Šušak Sporiš I; Božina N; Klarica Domjanović I; Sporiš D; Bašić S; Bašić I; Lovrić M; Ganoci L; Trkulja V
    Fundam Clin Pharmacol; 2024 Apr; 38(2):351-368. PubMed ID: 37793994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia.
    Li M; Kong XY; Wang SM
    Cancer Chemother Pharmacol; 2023 Jan; 91(1):77-87. PubMed ID: 36463535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
    Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
    Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.
    Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y
    Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy.
    Inoue K; Yamamoto Y; Suzuki E; Takahashi T; Umemura A; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
    Eur J Clin Pharmacol; 2016 May; 72(5):555-62. PubMed ID: 26790665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study.
    Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A
    J Antimicrob Chemother; 2018 Jun; 73(6):1659-1664. PubMed ID: 29509884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
    Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
    Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
    Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y
    Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of genetic polymorphisms on imatinib concentration and therapeutic response in patients with chronic-phase chronic myeloid leukemia.
    Cheng F; Cui Z; Li Q; Chen S; Li W; Zhang Y
    Int Immunopharmacol; 2024 May; 133():112090. PubMed ID: 38640718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Genetic Polymorphisms of ABCB1, ABCG2, and SLC22A1 on the Steady-State Plasma Concentrations of Lamotrigine in Treatment-Resistant Depressed Patients Treated With Lamotrigine Augmentation Therapy.
    Tomori Y; Suzuki T; Mihara K; Nagai G; Kagawa S; Nakamura A; Nemoto K; Kondo T
    Clin Neuropharmacol; 2024 Sep-Oct 01; 47(5):163-167. PubMed ID: 39171842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association analysis of ATP binding cassette protein family reveals a novel association of ABCB1 genetic variants with epilepsy risk, but not with drug-resistance.
    Balan S; Bharathan SP; Vellichiramal NN; Sathyan S; Joseph V; Radhakrishnan K; Banerjee M
    PLoS One; 2014; 9(2):e89253. PubMed ID: 24586633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.